Physician profile
Michael L Gluck
NPI 1437140837
$4,451.65
in general payments reported to CMS, 2019-2025
42 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 91% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $956 · 2020: $151 · 2021: $14.19 · 2022: $34.32 · 2023: $1,025 · 2024: $1,074 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,296.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $968.81 | 2021-2025 | |
| Lilly USA, LLC | $476.30 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $463.44 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $390.00 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $239.79 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $189.82 | 2019-2025 | Repatha, Otezla, Repatha |
| Phathom Pharmaceuticals, INC. | $170.55 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $150.80 | 2023-2025 | Cologuard Collection Kit |
| Comsort, INC | $150.00 | 2019 | |
| Pfizer INC. | $124.21 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $122.46 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $77.33 | 2019 | |
| Sumitomo Pharma America, INC. | $61.54 | 2025 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $57.52 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $56.59 | 2019-2025 | Airsupra, Breztri |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.